Oct 7 (Reuters) – AstraZeneca said on Tuesday its drug Baxdrostat met the main goal in a late-stage study in patients with treatment-resistant high blood pressure, or hypertension. (Reporting by Raechel Thankam Job in Bengaluru; Editing by Mrigank Dhaniwala)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Berlin (dpa) - Many women, younger ones too, wonder when they'll enter the menopause, the…
There are many habits you can teach your children to help prevent the spread of…
नई दिल्ली,29 अगस्त: सतीश सनपाल, जो यूएई स्थित उद्यमी और व्यवसायिक नेता हैं, ऐसे नेतृत्व…
सूरत फ्यूचर फाउंडेशन और शक्ति ग्रुप कंपनीज की इंडिया पोस्ट (सूरत डिवीज़न) के सहयोगसे पहल;…
More and more people are trusting influencers over doctors on health advice, despite many posts…
Here’s everything you need to know about diminishing under-eye bags – without in-clinic treatments. London…